Category Themes

Dérégler l’horloge d’ACTA

La petite ville guindée de Lucerne, en Suisse, accueille cette semaine le neuvième round de négociations visant à la signature de l’Accord Commercial Anti-Contrefaçon (plus connu sous sa dénomination anglaise, ACTA : Anti-Counterfeiting Trade Agreement). Pendant que les onze parties prenantes aux négociations devaient se retrouver au Palace Hotel, le Parti Pirate suisse et ses homologues allemands et autrichiens devaient organiser un rassemblement en gare de Lucerne.

Scope Of Anti-Counterfeiting Agreement Again A Big Issue In Round Nine

MUNICH - The staid little Swiss town of Lucerne this week sees round number nine of the negotiations for the Anti-Counterfeiting Trade Agreement (ACTA). While the 11 negotiating parties gather in the Palace Hotel, the Swiss Pirate Party together with their Pirate colleagues from Germany and Switzerland will organise a rally at the Lucerne train station.

High Expectations This Week For Progress On Exceptions And Limitations At WIPO

Limitations and exceptions are once again a major topic at the UN intellectual property organisation’s meeting on copyrights and related rights. Delegations this week are discussing several draft proposals to improve access, in particular for visually impaired people, each with their own set of recommendation. With a fourth and new proposal from the African countries on the table, delegates are meeting to try to find common ground, raising the expectations of civil society.

Comparative Analysis Shows US Patent Office Scores Poorly On Patent Quality

Quality across patent systems has been understudied but a new methodology put forward by the former chief economist of the European Patent Office suggests that the EPO provides higher quality services than its United States and Japan counterparts. Efforts at collaborative work between patent offices are being made but mutual recognition might not be possible or desirable without some harmonisation in the way the different systems operate.

The Biosimilars Pathway: An Invitation To Litigation

Lynn C. Tyler writes: The litigation provisions of the recently-enacted legislation establishing a pathway to bring biosimilars to market contain “patent” ambiguities in key areas, particularly whether the various lists of patents to be litigated are exclusive. Courts will have to resolve these issues over the next several years, likely at great (and unnecessary) expense and uncertainty to litigants.

Health Waiver, IP Enforcement Discussed At Lively WTO TRIPS Council Meeting

After two days of lively discussion, members of a World Trade Organization committee this week agreed to devote a day in October to an in-depth discussion on a waiver to WTO intellectual property rules aimed at boosting access to medicines for poor countries. In addition, some member countries presented concerns about the possible effect of a global enforcement push by developed countries and the Anti-Counterfeiting Trade Agreement (ACTA) under negotiation outside WTO, while ACTA proponent countries sought to allay fears.